Hint mode is switched on Switch off
For swift navigation between sections

Regeneron Ireland DAC
LEI 635400NABUOXXFAMHX81

Organization name
Regeneron Ireland Designated Activity Company
Country name
Ireland
Country of registration
Ireland
Industry
Pharmaceutical Preparation and Biotechnology
Public debt
1,684 mln USD

Upgrade to Premium features

Cbonds consolidates global bond, stock, ETF and indices data into a single platform — so you can analyze faster, make informed investment decisions and outperform the market

Get access
Welcome to Cbonds
  • Full access to the largest bond database

    Bond parameters,
    prospectuses

  • Seamless
    Data export

    Analyze the data in the most efficient way

  • Bond pricing

    Current & historical quotes from 400+ stock exchanges & OTC market

  • Smart risk assessment

    Credit ratings, financial reports

Latest data on

Get access to the largest financial database

Try in 7-days Demo access

Free for company representative

  • Evaluate advanced analytical tools
  • Get full online access to the database
  • Try our powerful bond screener
  • Track bond prices from 400+ sources

Quotes

Request sent
Access denied
Quotes provided by information providers are indicative in nature

Profile

Regeneron Ireland Designated Activity Company is a leading science and technology company delivering life-transforming treatments for serious diseases. Founded by physician-scientists over 30 years ago, its science-driven approach has resulted in nine FDA-approved medicines, eight EMA-approved medicines and numerous product candidates in a range of diseases, including asthma, pain, cancer and infectious diseases.

Awards

Documentation

Stocks

Latest issues

Public debt by currencies

Codes

  • LEI
    635400NABUOXXFAMHX81
Registration is required to get access.